Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Asthma
Interventions
DRUG

Budesonide 360ug

A single inhaled dose of 360ug budesonide from a DPI.

DRUG

Budesonide 720ug

A single inhaled dose of 720ug budesonide from a DPI.

DRUG

Budesonide 1440ug

A single dose of 1440ug of the budesonide from DPI.

DRUG

Budesonide720ug 4 times

720ug of budesonide will be inhaled by the subjects 4 times, separated by 30 minutes.

DRUG

Placebo

A single inhaled dose of placebo from a DPI.

Trial Locations (1)

33136

Pulmonary Human Research Laboratory, University of Miami, Miller School of Medicine, Miami

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Miami

OTHER

NCT01219738 - Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide | Biotech Hunter | Biotech Hunter